Newron Pharmaceuticals (NWPHF) Short Interest Ratio & Short Volume → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free NWPHF Stock Alerts $12.00 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Newron Pharmaceuticals Short Interest DataCurrent Short Interest28,200 sharesPrevious Short Interest100 sharesChange Vs. Previous Month+28,100.00%Dollar Volume Sold Short$240,264.00Short Interest Ratio282.0 Days to CoverLast Record DateApril 30, 2024Outstanding Shares17,850,000 sharesPercentage of Shares Shorted0.16%Today's Trading Volume0 sharesAverage Trading Volume1,525 sharesToday's Volume Vs. Average0% Short Selling Newron Pharmaceuticals ? Sign up to receive the latest short interest report for Newron Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNWPHF Short Interest Over TimeNWPHF Days to Cover Over TimeNWPHF Percentage of Float Shorted Over Time Ad InvestorPlaceRead this before you buy AI stocksBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. Newron Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202428,200 shares $240,264.00 +28,100.0%N/A282 $8.52 4/15/2024100 shares $852.00 -99.8%N/A0 $8.52 3/31/202444,600 shares $379,992.00 +50.7%N/A0 $8.52 3/15/202429,600 shares $252,192.00 +60.0%N/A0 $8.52 2/29/202418,500 shares $157,620.00 +537.9%N/A0 $8.52 2/15/20242,900 shares $24,708.00 +480.0%N/A0 $8.52 Get the Latest News and Ratings for NWPHF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Newron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,700 shares $21,330.00 -89.2%N/A6.8 $7.90 12/31/202324,900 shares $129,978.00 +66.0%N/A101.9 $5.22 12/15/202315,000 shares $93,300.00 -35.3%N/A0 $6.22 11/30/202323,200 shares $144,304.00 -27.0%N/A0 $6.22 11/15/202331,800 shares $197,796.00 +27.2%N/A0 $6.22 10/31/202325,000 shares $155,500.00 +24,900.0%N/A0 $6.22 10/15/2023100 shares $622.00 -99.5%N/A0 $6.22 9/30/202318,600 shares $115,692.00 -22.5%N/A0 $6.22 9/15/202324,000 shares $149,280.00 +566.7%N/A0 $6.22 8/31/20233,600 shares $22,392.00 -63.3%N/A35 $6.22 8/15/20239,800 shares $19,796.00 -10.9%N/A0 $2.02 7/31/202311,000 shares $22,220.00 +10,900.0%N/A0 $2.02 7/15/2023100 shares $202.00 No ChangeN/A1 $2.02 6/30/2023100 shares $202.00 No ChangeN/A0 $2.02 6/15/2023100 shares $202.00 No ChangeN/A0 $2.02 5/31/2023100 shares $202.00 -97.1%N/A0 $2.02 5/15/20233,500 shares $7,070.00 +3,400.0%N/A0 $2.02 4/30/2023100 shares $202.00 -99.5%N/A0 $2.02 4/15/202319,200 shares $38,784.00 -70.4%N/A0 $2.02 3/31/202364,900 shares $131,098.00 -35.5%N/A0 $2.02 3/15/2023100,600 shares $203,212.00 +21.5%N/A0 $2.02 2/28/202382,800 shares $167,256.00 +82,700.0%N/A828 $2.02 2/15/2023100 shares $202.00 -91.7%N/A0 $2.02 1/31/20231,200 shares $2,424.00 +1,100.0%N/A0 $2.02 1/15/2023100 shares $202.00 No ChangeN/A1 $2.02 12/15/2022100 shares $210.00 No ChangeN/A0 $2.10 11/30/2022100 shares $210.00 No ChangeN/A0 $2.10 11/15/2022100 shares $210.00 No ChangeN/A0 $2.10 10/31/2022100 shares $210.00 No ChangeN/A0 $2.10 10/15/2022100 shares $210.00 No ChangeN/A0 $2.10 9/30/2022100 shares $210.00 No ChangeN/A0 $2.10 9/15/2022100 shares $210.00 No ChangeN/A0 $2.10 8/31/2022100 shares $210.00 No ChangeN/A0 $2.10 8/15/2022100 shares $210.00 No ChangeN/A0 $2.10Read this before you buy AI stocks (Ad)BREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. 7/31/2022100 shares $210.00 No ChangeN/A0 $2.10 7/15/2022100 shares $210.00 No ChangeN/A0 $2.10 6/30/2022100 shares $210.00 No ChangeN/A0 $2.10 6/15/2022100 shares $210.00 No ChangeN/A0 $2.10 5/31/2022100 shares $210.00 No ChangeN/A0 $2.10 5/15/2022100 shares $210.00 No ChangeN/A0 $2.10 4/30/2022100 shares $210.00 No ChangeN/A0 $2.10 4/15/2022100 shares $210.00 No ChangeN/A0 $2.10 3/31/2022100 shares $210.00 No ChangeN/A0 $2.10 3/15/2022100 shares $210.00 No ChangeN/A0 $2.10 2/28/2022100 shares $210.00 No ChangeN/A0 $2.10 2/15/2022100 shares $210.00 No ChangeN/A0 $2.10 1/31/2022100 shares $210.00 No ChangeN/A0 $2.10 1/15/2022100 shares $210.00 No ChangeN/A0 $2.10 12/31/2021100 shares $210.00 No ChangeN/A0.3 $2.10 12/15/2021100 shares $280.00 No ChangeN/A0 $2.80 11/30/2021100 shares $280.00 No ChangeN/A0 $2.80 11/15/2021100 shares $280.00 No ChangeN/A0 $2.80 10/29/2021100 shares $280.00 No ChangeN/A0 $2.80 10/15/2021100 shares $280.00 No ChangeN/A0 $2.80 9/30/2021100 shares $280.00 No ChangeN/A0 $2.80 9/15/2021100 shares $280.00 No ChangeN/A0 $2.80 8/31/2021100 shares $280.00 -98.7%N/A0 $2.80 8/13/20217,700 shares $21,560.00 +7,600.0%N/A0 $2.80 7/30/2021100 shares $280.00 No ChangeN/A0 $2.80 7/15/2021100 shares $280.00 No ChangeN/A0 $2.80 6/30/2021100 shares $280.00 No ChangeN/A0 $2.80 6/15/2021100 shares $280.00 No ChangeN/A0.1 $2.80 5/28/2021100 shares $280.00 No ChangeN/A1 $2.80 5/14/2021100 shares $280.00 No ChangeN/A0 $2.80 4/30/2021100 shares $280.00 No ChangeN/A0 $2.80 4/15/2021100 shares $280.00 No ChangeN/A0 $2.80 3/31/2021100 shares $300.00 -98.1%N/A0.5 $3.00 3/15/20215,300 shares $12,935.18 +5,200.0%N/A2.8 $2.44 2/26/2021100 shares $244.06 No ChangeN/A0 $2.44 2/12/2021100 shares $244.06 -92.9%N/A0 $2.44 1/29/20211,400 shares $3,416.84 +1,300.0%N/A0 $2.44 1/15/2021100 shares $244.06 No ChangeN/A0 $2.44 12/31/2020100 shares $244.06 No ChangeN/A0.1 $2.44 12/15/2020100 shares $247.00 No ChangeN/A0 $2.47 11/30/2020100 shares $196.29 No ChangeN/A0 $1.96 11/15/2020100 shares $196.29 No ChangeN/A0.1 $1.96 10/30/2020100 shares $190.00 No ChangeN/A1 $1.90 10/15/2020100 shares $202.00 -93.8%N/A0.5 $2.02 9/30/20201,600 shares $4,080.00 +1,500.0%N/A0 $2.55 9/15/2020100 shares $255.00 No ChangeN/A0 $2.55 8/31/2020100 shares $255.00 -90.0%N/A1 $2.55 8/14/20201,000 shares $2,500.00 +900.0%N/A10 $2.50 7/31/2020100 shares $181.00 No ChangeN/A0 $1.81 7/15/2020100 shares $181.00 No ChangeN/A0 $1.81Read this before you buy AI stocks (Ad)BREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. 6/30/2020100 shares $181.00 No ChangeN/A0.2 $1.81 6/15/2020100 shares $180.10 No ChangeN/A0.2 $1.80 5/29/2020100 shares $890.00 No ChangeN/A1 $8.90 5/15/2020100 shares $750.00 -99.3%N/A1 $7.50 4/30/202014,000 shares $105,000.00 +25.0%N/A0 $7.50 4/15/202011,200 shares $84,000.00 -69.1%N/A0 $7.50 3/31/202036,200 shares $271,500.00 +44.8%N/A0 $7.50 3/13/202025,000 shares $187,500.00 No ChangeN/A250 $7.50 2/28/202025,000 shares $187,500.00 No ChangeN/A0 $7.50 2/14/202025,000 shares $187,500.00 No ChangeN/A0 $7.50 1/31/202025,000 shares $187,500.00 No ChangeN/A0 $7.50 1/15/202025,000 shares $187,500.00 -1.2%N/A250 $7.50 12/31/201925,300 shares $189,750.00 -41.4%N/A0 $7.50 NWPHF Short Interest - Frequently Asked Questions What is Newron Pharmaceuticals' current short interest? Short interest is the volume of Newron Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 28,200 shares of NWPHF short. Learn More on Newron Pharmaceuticals' current short interest. What is a good short interest ratio for Newron Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NWPHF shares currently have a short interest ratio of 282.0. Learn More on Newron Pharmaceuticals's short interest ratio. Is Newron Pharmaceuticals' short interest increasing or decreasing? Newron Pharmaceuticals saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 28,200 shares, an increase of 28,100.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Newron Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Newron Pharmaceuticals: Trevi Therapeutics, Inc. (1.49%), Zevra Therapeutics, Inc. (6.15%), Conduit Pharmaceuticals Inc. (0.42%), Incannex Healthcare Inc. (0.48%), Atossa Therapeutics, Inc. (9.10%), Werewolf Therapeutics, Inc. (1.39%), Veru Inc. (8.35%), Inventiva S.A. (0.13%), Organigram Holdings Inc. (5.87%), Acrivon Therapeutics, Inc. (5.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Newron Pharmaceuticals stock? Short selling NWPHF is an investing strategy that aims to generate trading profit from Newron Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Newron Pharmaceuticals? A short squeeze for Newron Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NWPHF, which in turn drives the price of the stock up even further. How often is Newron Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NWPHF, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Trevi Therapeutics Short Squeeze Zevra Therapeutics Short Squeeze Conduit Pharmaceuticals Short Squeeze Incannex Healthcare Short Squeeze Atossa Therapeutics Short Squeeze Werewolf Therapeutics Short Squeeze Veru Short Squeeze Inventiva Short Squeeze Organigram Short Squeeze Acrivon Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NWPHF) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestThis military-backed stock “owns” AI marketPorter & CompanyNew Options need New Trading StrategiesNetpicks